Corpus ID: 201161418

Primed for Psychiatry: The role of artificial intelligence and machine learning in the optimization of depression treatment

  title={Primed for Psychiatry: The role of artificial intelligence and machine learning in the optimization of depression treatment},
  author={J. Tan and C. Rollins and S. Israel and D. Benrimoh},
  journal={University of Toronto Medical Journal},
Depression is a leading source of medical disability and is experienced by over 322 million people worldwide. Despite its increasingly significant burden and a pressing need for effective treatment, depression has been persistently difficult to treat. Current common practice for treatment selection is an educated guess-and-check approach, in which clinicians prescribe one of the numerous approved therapies for depression in a stepwise manner. Though evidence-based clinical guidelines for… Expand
RNNs for detecting depression in Huntington’s Disease
Huntington’s Disease (HD) is a neurodegenerative disorder characterized by motor, cognitive and psychiatric progressive dysfunctions, caused by a genetic mutation on a protein whose function remainsExpand
Improving Mental Health Services: A 50-Year Journey from Randomized Experiments to Artificial Intelligence and Precision Mental Health
  • L. Bickman
  • Psychology, Medicine
  • Administration and Policy in Mental Health and Mental Health Services Research
  • 2020
This conceptual paper describes the current state of mental health services, identifies critical problems, and suggests how to solve them and identifies exemplars from the emerging literature on artificial intelligence and precision approaches to treatment. Expand


A systematic meta-review of predictors of antidepressant treatment outcome in major depressive disorder.
A meta-review is conducted to identify predictors of response to antidepressant therapy in order to select robust input features for machine learning models of treatment response, and highlights the importance of large-scale research initiatives and clinically accessible biomarkers. Expand
Aifred Health , a Deep Learning Powered Clinical Decision Support System for Mental Health
Aifred Health, one of the top two teams in the first round of the IBM Watson AI XPRIZE competition, is using deep learning to solve the problem of treatment selection and prognosis prediction inExpand
Understanding the somatic consequences of depression: biological mechanisms and the role of depression symptom profile
The heterogeneity of the depression concept seems to play a differentiating role: metabolic syndrome and inflammation up-regulations appear more specific to the atypical depression subtype, whereas hypercortisolemia appears more specific for melancholic depression. Expand
Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder
Evidence-based pharmacological treatments are available for first-line treatment of major depressive disorder and for management of inadequate response, however, given the limitations of the evidence base, pharmacological management of MDD still depends on tailoring treatments to the patient. Expand
Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder
For MDD of mild to moderate severity, exercise, light therapy, St. John’s wort, omega-3 fatty acids, SAM-e, and yoga are recommended as first- or second-line treatments. Expand
Big data analytics and machine learning: 2015 and beyond.
Findings from a large twin study of white matter structure in schizophrenia showed a strong association between white matter integrity and genetic risk for schizophrenia, suggesting a potential common causal genetic mechanism, and the organising theme of anatomically distributed, large-scale connectivity networks has made contact with genomics. Expand
Deep Learning-A Technology With the Potential to Transform Health Care.
The purpose of this Viewpoint is to give health care professionals an intuitive understanding of the technology underlying deep learning, used on billions of digital devices for complex tasks such as speech recognition, image interpretation, and language translation. Expand
How many different symptom combinations fulfil the diagnostic criteria for major depressive disorder? Results from the CRESCEND study
The findings support the criticism that the diagnosis of MDD is not based on a single mental process, but on a set of ‘family resemblances’. Expand
Why don't psychiatrists use scales to measure outcome when treating depressed patients?
If standardized outcome assessment is to assume increasing importance in this country, either educational efforts or payor mandates, or both, will be necessary to change clinicians' behavior. Expand
Measurement-Based Care in Psychiatry.
It will be important for providers and organizations to consider MBC as an evidence-based framework to reduce variability in psychiatric treatment and improve patient outcomes as mental health care moves in the direction of value-driven incentives. Expand